Another study has documented that metformin counteracts HCC cell proliferation markedly via increasing cells arrested at the G2/M phase, dependent on the suppressing effect of miR-378 on CDK1 expression (31). This evidence concerns the gene CDK1 and hepatocellular carcinoma.